Home About Us Contact Us

 

Table of Content - Volume 7 Issue 2 - August 2017


 

A study of association of metabolic syndrome and psoriasis at tertiary health care centre

 

T V Ramana Rao1*, Prathyusha Y2, Ajay Kumar Reddy Bobba3

 

1,2Assistant Professor, Department of Dermatology, Gayatri Vidya Parishad Institute of Health care and Medical Technology, INDIA.

3Assistant Professor, Department of Community Medicine, Pinnamaneni Siddardha Institute of Medical Sciences, INDIA.

Email: drtvramanarao94404@gmail.com

 

REFERENCES

        1. Davidovici BB, Sattar N, Prinz JC, Jörg PC, Puig L, Emery P, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010; 130: 1785–96.
        2. Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital based case control study. Indian Journal of Dermatology 2012; 57(5):353-357.
        3. Nisa N, Qazi M. Prevalence of metabolic syndrome in patients with psoriasis. Ind J Dermatol Venereol Leprol 2010; 76: 662-665.
        4. Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol. 2011; 147(4):419-24.
        5. Gisondi P, Tessari G,Conti A, Piaserico S,Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: A hospital- based case-control study. Br J Dermatol 2007; 157:68-73.
        6. Khunger N, Gupta D, Ramesh V. Is psoriasis a new marker for Metabolic syndrome? A study in Indian patients.Indian J Dermatol 2013; 58(4):313-4.
        7. Hydrie MZ, Shera AS, Fawwad A, Basit A, Hussain A. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria.Metab Syndr Relat Disord 2009; 7(2):119-24.
        8. Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352:1899-912.
        9. Shenoy C, Shenoy MM, Rao GK. Dyslipidemia in dermatological disorders. N Am J Med Sci 2015; 7:421‑8.
        10. Aruna C, Rao GV, Ramanamurthy P, Rambabu P. Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case control study from a tertiary care center in Andhra Pradesh. J NTR Univ Health Sci 2016; 5:13-6.
        11. Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SB, Mehta NN, Margolis DJ, Gelfand JM. Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom. Journal of Investigative Dermatology 2012; 132: 556–562
        12. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the MetS in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298:321-8.
        13. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013; 68:654-662.
        14. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Lizuka H. Prevalence of obesity/adiposity in Japanese psoriasis patients: Adiposity is correlated with the severity of psoriasis. J Dermatol Sci 2009; 55:74-6.
Journal Menu MIJOMED Medpulse Manuscript Submission Subscription Aim & Scope Peer Review Process Publication Ethics & Malpractice Statement Open Access Statement Plagiarism Policy Editorial Board Indexing Current Issue Publication Charges Archives Authors Information Copyright & Licensing Privacy Statement Contact Us